245 related articles for article (PubMed ID: 8021727)
21. [Immunoproliferative small intestinal disease (IPSID): IPSID-like lymphomas, IPSID equivalents?, in 12 Spanish patients].
Sánchez-Fayos Calabuig P; Hernández Guío C; Porres Cubero JC; Olavarría López-Aróstegui E; Rivas Manga C; Outeiriño Hernanz J; Sánchez Fayos J
Sangre (Barc); 1995 Dec; 40(6):485-9. PubMed ID: 8850232
[TBL] [Abstract][Full Text] [Related]
22. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
[TBL] [Abstract][Full Text] [Related]
23. Immunoproliferative small intestinal disease (IPSID).
Pervez S; Mumtaz K; Ullah SS; Akhtar N; Ali N; Aaqil H
J Coll Physicians Surg Pak; 2011 Jan; 21(1):57-8. PubMed ID: 21276391
[TBL] [Abstract][Full Text] [Related]
24. "Mediterranean abdominal lymphoma" or immunoproliferative small intestinal disease. Part II: pathological aspects.
Nassar VH; Salem PA; Shahid MJ; Alami SY; Balikian JB; Salem AA; Nasrallah SM
Cancer; 1978 Apr; 41(4):1340-54. PubMed ID: 416903
[TBL] [Abstract][Full Text] [Related]
25. Is immunoproliferative small intestinal disease uncommon in India?
Ghoshal UC; Chetri K; Banerjee PK; Choudhuri G; Pal BB; Dabadghao S; Dhar K; Naik S; Naik SR
Trop Gastroenterol; 2001; 22(1):14-7. PubMed ID: 11398237
[TBL] [Abstract][Full Text] [Related]
26. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
Al-Saleem T; Al-Mondhiry H
Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584
[TBL] [Abstract][Full Text] [Related]
27. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study.
Willich NA; Reinartz G; Horst EJ; Delker G; Reers B; Hiddemann W; Tiemann M; Parwaresch R; Grothaus-Pinke B; Kocik J; Koch P
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):895-901. PubMed ID: 10705011
[TBL] [Abstract][Full Text] [Related]
28. Immunoproliferative small intestinal disease (IPSID) in Thailand.
Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
30. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
Zahner J; Kirchner T; Ott G; Schneider W
Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.
Jones SE; Miller TP; Connors JM
J Clin Oncol; 1989 Sep; 7(9):1186-91. PubMed ID: 2671279
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
35. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast.
Seker M; Bilici A; Ustaalioglu BO; Yilmaz B; Ozturk B; Ünal A; Dane F; Ozdemir NY; Elkiran ET; Kalender ME; Gumus M; Benekli M
Arch Gynecol Obstet; 2011 Aug; 284(2):405-9. PubMed ID: 20872226
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
38. Non-IPSID small intestinal lymphoma: evidence for disseminated disease at presentation.
Milanović N; Jelić S; Jovanović V; Kovcin V; Oprić M; Marinković M
Neoplasma; 1994; 41(6):359-62. PubMed ID: 7870221
[TBL] [Abstract][Full Text] [Related]
39. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy of Mediterranean abdominal lymphoma. Retrospective comparison of chemotherapy protocols in Iranian patients.
Salimi M; Spinelli JJ
Am J Clin Oncol; 1996 Feb; 19(1):18-22. PubMed ID: 8554029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
